Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

Search

Top

VITAE ENIM VITAE SCIENTIFIC, INC. San Diego CA 92109 USA

UEI: SLED_C20DF93902B83321

VITAE ENIM VITAE SCIENTIFIC, INC. San Diego CA 92109 USA is a federal contractor, registered under UEI SLED_C20DF93902B83321. It has been awarded $49,885,704 across 1 federal contract. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include National Institutes Of Health Nida.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_C20DF93902B83321

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

National Institutes Of Health Nida$49.9M100%

Awards by NAICS

325412 - Pharmaceutical Preparation Manufacturing$49.9M100%

Awards by Agency Over Time

Awards by Place of Performance

Compete with VITAE ENIM VITAE SCIENTIFIC, INC. San Diego CA 92109 USA

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for VITAE ENIM VITAE SCIENTIFIC, INC. San Diego CA 92109 USA

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in VITAE ENIM VITAE SCIENTIFIC, INC. San Diego CA 92109 USA's top NAICS codes and agencies

Latanoprost Ophthalmic Solution ManufacturingThis subcontract involves the manufacturing of Latanoprost Ophthalmic Solution to support prime contractors on pharmaceutical procurement projects for the Department of Veterans Affairs. The scope of work encompasses the entire production process, including chemical synthesis, formulation, and sterile filling into ocular medication containers. All operations must be conducted within cleanrooms using pharmaceutical-grade API and in strict adherence to current Good Manufacturing Practices. To ensure safety and standardization, the manufacturer must follow the American Academy of Ophthalmology’s uniform color-coding system for all labels and caps. The final deliverable consists of finished, labeled, and packaged solutions assigned a unique NDC number. This project is categorized under NAICS code 325412 and is managed through Nac Pharmaceuticals.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--Latanoprost Ophthalmic Solution (VA-27-00006027)

Solicitation # 36E79727R0039

The Department of Veterans Affairs Enterprise Procurement Office intends to issue Request for Proposal 36E79727R0039 for an unrestricted procurement of Latanoprost Ophthalmic Solution. This contract will establish an uninterrupted source of supply for the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The award will be granted to a single responsible offeror for a base period of one year with four pre-priced one-year option periods. The solicitation is expected to be issued in commercial item format per FAR Part 12 on approximately October 21, 2026, with a tentative closing date of November 4, 2026. Strict labeling and packaging requirements apply to this procurement. Offerors must provide a unique NDC number and the exact drug name as it appears on the label. The contractor's label must be the only one on the product, and affixing labels over existing ones is prohibited; however, the product must allow VA labels to adhere securely on top. Additionally, vendors must comply with the American Academy of Ophthalmology’s recommended uniform color-coding system for the caps and labels of all topical ocular medications. This acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements, and all electronic communications and submissions will be handled via SAM.gov.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Supply of Bismuth Subsalicylate SuspensionThis subcontract involves the supply of finished pharmaceutical products to prime contractors supporting DLA Troop Support medical supply contracts. The specific requirement is for the delivery of 2,000 bottles of Bismuth Subsalicylate Suspension, with a strength of 262 MG/15 ML in 240 ML bottles, identified by NSN 6505015056483. All deliverables must strictly adhere to RP001 DLA Packaging Requirements for Procurement. Managed by the Department of Defense under the Medical Supply Chain Pharm FSA, the contract is categorized under NAICS code 325412. The designated place of performance is Fort Drum, New York. The solicitation was posted on October 1, 2026, with a response deadline of October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Ibuprofen Oral Suspension, USPThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of pharmaceutical-grade Ibuprofen Oral Suspension, USP, for prime contractors. The required product must match NSN 6505-01-316-5049 and adhere strictly to United States Pharmacopeia standards. Deliverables consist of completed bottles utilizing commercial packaging and packing standards, with a mandatory non-extendable shelf life of 24 months. The opportunity is categorized under NAICS code 325412 and was posted on October 1, 2026, with a response deadline of October 7, 2026. This procurement is managed by DLA Troop Support to ensure the availability of critical medical supplies for military operations.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Occlusive Adhesive Dressing SupplierThis subcontract opportunity is for a supplier to provide occlusive adhesive dressings for prime contractors supporting Medical Supply Chain MD SURG FSF projects under the Department of Defense. The selected provider must manufacture or source dressings that strictly adhere to established technical specifications. All units must be packed in sealed containers and commercial exterior shipping containers for transport via common carrier, requiring the supplier to maintain a CAGE code and follow standard commercial packaging guidelines. The project is categorized under NAICS code 325412 and will be performed in Springfield, Missouri. Interested parties must respond by October 7, 2026, to be considered for the delivery of these physical medical supplies.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Albendazole Tablets, USPThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Albendazole Tablets, USP, for prime contractors supporting DLA Troop Support medical supply contracts. The requirement is for 168 bottles of tablets under NSN 6505-01-649-3422, which must meet all USP specifications and be delivered FOB Destination to Fort Bragg. The supplier must maintain FDA registration and ensure the product is packaged in bottles with a non-extendable 24-month shelf life, designated as Type I, Code M. This procurement falls under NAICS code 325412, with a response deadline set for October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Poison Ivy Skin WashThis subcontract opportunity is for a supplier to provide Poison Ivy Skin Wash, identified by NSN 6505-01-611-2071, to support prime contractors on DLA Troop Support medical supply chain projects. The Department of Defense, specifically the Medical Supply Chain Pharm FSA, requires the product to be delivered to a designated facility in Colchester, Vermont. All supplies must adhere to strict pharmaceutical quality standards and comply with FAR 52.223-23. Eligible providers must be registered as medical or pharmaceutical supply providers under NAICS code 325412. The solicitation was posted on October 1, 2026, with a response deadline of October 7, 2026. The selected supplier will be responsible for the physical delivery of the end items to the specified government location.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Multiple Electrolytes Injection, Type 1This subcontract involves the manufacture and supply of Multiple Electrolytes Injection, Type 1, for prime contractors supporting Department of Defense projects under the DLA Troop Support Medical Supply Chain. The required pharmaceutical products must be USP-compliant with a pH of 7.4, provided in 1000 ML latex-free plastic bags. Deliveries consist of NSN 6505014625492 in units of 14 per package, with strict adherence to room temperature storage standards and MIL-STD-129 marking and shipment regulations. The project is categorized under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA. Performance for this contract is centered at Fort Bragg, zip code 28310. Interested parties should note the posting date of October 1, 2026, with a response deadline set for October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Loperamide Hydrochloride CapsulesThis subcontract involves the supply of 2,000 bottles of Loperamide Hydrochloride Capsules, each containing 500 capsules of 2mg strength, to support prime contractors for the Department of Defense Medical Supply Chain Pharm FSA. The medication must be pharmaceutical-grade and strictly compliant with NSN 6505012813558, requiring the provider to maintain valid FDA approval and necessary pharmaceutical licensure. Performance of this contract takes place at Fort Bragg and requires strict adherence to DLA packaging requirements RP001 and hazardous materials standards IP025. The procurement falls under NAICS code 325412, with a response deadline set for October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Fluconazole Tablets 150 MGThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the manufacture and supply of pharmaceutical-grade Fluconazole Tablets 150 MG. The contractor is responsible for providing the medication in individually sealed blister strips of 12 tablets, ensuring all products meet strict FDA manufacturing standards and DLA packaging specifications. The contract requires adherence to TYPE I (CODE M) shelf-life requirements, specifically a non-extendable shelf life of 24 months. Performance for this requirement is centered at Fort Drum, New York, under NAICS code 325412. The solicitation was posted on October 1, 2026, with a response deadline of October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Ceftriaxone Sodium in Dextrose InjectionThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Ceftriaxone Sodium in Dextrose Injection to prime contractors for DLA Troop Support medical supply contracts. The requirement is for five packages, each containing 24 plastic bags of 1 gram Ceftriaxone frozen and premixed in an iso-osmotic solution with 1.9 gram dextrose. To ensure product integrity, the contractor must utilize cold-chain storage and transport equipment to maintain a temperature of -20 degrees Celsius per USP standards, with packaging adhering to MIL-STD-2073-1E. The performance location for this contract is FPO 09566-4008, and the response deadline is October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Lactated Ringer's Injection, USPThis subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Lactated Ringer's Injection, USP, in 500 ML containers for prime contractors on DLA Troop Support medical supply contracts. The provider is responsible for manufacturing or sourcing pharmaceutical solutions that strictly adhere to USP standards, with products packaged in units of 24 containers. Operational requirements include the use of USP-compliant manufacturing facilities and the maintenance of temperature-controlled storage at 25 degrees Celsius. All deliverables must comply with RP001, MIL-STD-2073-1E, and RA001 standards. The opportunity is categorized under NAICS code 325412, with a response deadline of October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing (Pentobarbital Sodium)This subcontract involves the manufacture and supply of 20,000 units of pharmaceutical grade Pentobarbital Sodium (NSN 6509-01-485-6206) for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The scope of work encompasses the entire production lifecycle, including chemical synthesis, formulation, and rigorous quality control testing to ensure purity. All materials must be packaged in clean-room facilities using specialized pharmaceutical equipment in accordance with MIL-STD-2073-1E standards. Due to the nature of the substance, the performing entity must maintain active FDA and DEA registrations for handling controlled substances. The project falls under NAICS code 325412 and is designated for performance at APO 96368-5268. Interested parties should note the tight response window following the October 1, 2026, posting date.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Chlorhexidine Prep SwabsticksThis subcontract opportunity with the Department of Defense Medical Supply Chain involves the manufacture or distribution of sterile chlorhexidine gluconate swabsticks used for skin disinfection. These products must be produced using pharmaceutical grade antiseptic and applicator sticks, ensuring they meet strict sterile medical packaging requirements. The specific delivery requirement consists of 25 packages, with each package containing three swabsticks. The contract is categorized under NAICS code 325412 and is intended for prime contractors supporting DLA Troop Support medical supply contracts. Interested parties should note the posting date of October 1, 2026, with a response deadline set for October 7, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Sodium Chloride 0.9% Injection (USP)This subcontract involves the supply of Sodium Chloride 0.9% Injection, USP 500 ML, to support prime contractors on Department of Defense projects managed by the DLA Troop Support Medical Supply Chain. The required product must adhere to USP standards and be delivered in sealed unit containers within commercial exterior shipping containers to ensure product integrity. Shipments are specified as 24 units per NSN 6505013306268. Eligible providers must hold valid pharmaceutical manufacturing or distribution licenses. The contract falls under NAICS code 325412 and specifies Rochester as the place of performance. Interested parties must respond by October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Dibucaine Ointment Supply (USP Grade)This subcontract involves the manufacture and supply of USP grade Dibucaine Ointment for prime contractors supporting the Department of Defense Medical Supply Chain. The required product must contain a 1 percent active ingredient meeting United States Pharmacopeia specifications and be packaged in collapsible tubes with rectal applicators. Each delivery consists of six packages of 1 ounce tubes, and the supplier must adhere to strict quality assurance standards under FAR 52.246-2. Logistical requirements include maintaining precise storage temperature controls between 15 and 30 degrees Celsius. The contract is managed by the Medical Supply Chain Pharm FSA and specifies a place of performance in Starke, Florida. Interested parties must adhere to the established timeline, with a response deadline set for October 7, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Docusate Calcium CapsulesThis subcontract involves the supply of Docusate Calcium Capsules USP 240MG to prime contractors supporting Department of Defense medical supply contracts through the Medical Supply Chain Pharm FSA. The requirement specifies the delivery of bottles containing 500 capsules, with a strict mandate for FDA regulation compliance and adherence to United States Pharmacopeia specifications. To maintain a non-extendable shelf-life of 30 months, the provider must ensure medical controlled room temperature is maintained throughout both storage and transport. The place of performance for this contract is located at Fort Drum, New York, under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of NSN 8520013469200This subcontract involves the procurement of material identified by NSN 8520013469200 to support prime contractors on Department of Defense projects managed by the DLA Troop Support Medical Supply Chain. The selected supplier is responsible for manufacturing or sourcing the specific chemical or pharmaceutical product, ensuring it meets all technical specifications, quality, and safety standards associated with the NSN. The contractor must handle the packaging and shipping of the material in accordance with DLA medical supply chain standards for delivery in specified quantities. Performance for this contract is centered in Minot, with the opportunity posted on October 1, 2026, and a response deadline of October 7, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE